Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGossamer Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$0.22 | -$0.15 | -$0.19 |
| Q2 2025 | 4 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2025 | 4 | -$0.20 | -$0.20 | -$0.20 |
| Q4 2025 | 4 | -$0.16 | -$0.16 | -$0.16 |
| Q1 2026 | 3 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2026 | 3 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2026 | 3 | -$0.14 | -$0.14 | -$0.14 |
| Q4 2026 | 3 | -$0.09 | -$0.09 | -$0.09 |
Gossamer Bio, Inc. Earnings Date And Information
Gossamer Bio, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.14 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.04. The company had revenue of 9.48 M for the quarter and had revenue of 0 for the year. Gossamer Bio, Inc. has generated $-1 earnings per share over the last year ($-1.18 diluted earnings per share) and currently has a price-to-earnings ratio of -4.11. Gossamer Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Gossamer Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.18 | -$0.14 | 0.04 | $8.53 M | $9.48 M |
| 08/12/2024 | Q2 2024 | $0.23 | $0.22 | -0.01 | $114.29 M | $95.84 M |
| 05/07/2024 | Q1 2024 | -$0.19 | -$0.19 | 0 | N/A | $0 |
| 03/05/2024 | Q4 2023 | -$0.20 | -$0.21 | -0.01 | N/A | $6.78 M |
| 11/09/2023 | Q3 2023 | -$0.20 | -$0.21 | -0.01 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.49 | -$0.45 | 0.04 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$0.55 | -$0.57 | -0.02 | N/A | $0 |
| 03/17/2023 | Q4 2022 | -$0.62 | -$0.61 | 0.01 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$0.66 | -$0.69 | -0.03 | N/A | $0 |
| 08/09/2022 | Q2 2022 | -$0.67 | -$0.77 | -0.1 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$0.77 | -$0.81 | -0.04 | N/A | $0 |
| 03/03/2022 | Q4 2021 | -$0.74 | -$0.74 | 0 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.78 | -$0.80 | -0.02 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.77 | -$0.80 | -0.03 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$0.80 | -$0.78 | 0.02 | N/A | $0 |
| 02/26/2021 | Q4 2020 | N/A | -$0.88 | N/A | N/A | $0 |
| 11/10/2020 | Q3 2020 | -$0.86 | -$0.80 | 0.06 | N/A | $0 |
| 08/11/2020 | Q2 2020 | -$0.84 | -$1.00 | -0.16 | N/A | $0 |
| 05/12/2020 | Q1 2020 | -$0.80 | -$0.87 | -0.07 | N/A | $0 |
| 03/24/2020 | Q4 2019 | -$0.80 | -$0.89 | -0.09 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gossamer Bio, Inc. Earnings: FAQ's
Gossamer Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based offlast year's report dates.
In the previous quarter, Gossamer Bio, Inc. (:GOSS) reported $-0.14 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.04.
The conference call for Gossamer Bio, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Gossamer Bio, Inc.'s latest earnings report can be read online.
Gossamer Bio, Inc. (:GOSS) has a recorded net income of $-179,817,000.Gossamer Bio, Inc. has generated $-1.18 earnings per share over the last four quarters.
Gossamer Bio, Inc. (:GOSS) has a price-to-earnings ratio of -4.11 and price/earnings-to-growth ratio is -0.23.